Trial Profile
Fidaxomicin Use for Clostridium difficile Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 21 Oct 2015 New trial record
- 19 Sep 2015 Results presented at Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.